John P. Sharp
Overview
John P. Sharp received an average of $710K in total compensation, including $366K in salary, at PhaseBio Pharmaceuticals from 2018 to 2021. John Sharp also received an average of $490K at Ligand Pharmaceuticals from 2007 to 2014.
- 2021
- 2020
- 2019
- 2018
- 2014
- 2013
- 2012
- 2011
- 2010
- 2008
PhaseBio PharmaceuticalsChief Financial Officer
PhaseBio PharmaceuticalsChief Financial Officer
PhaseBio PharmaceuticalsChief Financial Officer
PhaseBio PharmaceuticalsChief Financial Officer
Ligand PharmaceuticalsFormer VP, Finance and Chief Financial Officer
Ligand PharmaceuticalsFormer VP, Finance and Chief Financial Officer
Ligand PharmaceuticalsFormer VP, Finance and Chief Financial Officer
Ligand PharmaceuticalsFormer VP, Finance and Chief Financial Officer
Ligand PharmaceuticalsVice President, Finance and Chief Financial Officer
Ligand PharmaceuticalsVice President, Finance and Chief Financial Officer
Source: SEC filings on April 22, 2022, April 24, 2020, March 12, 2015, April 21, 2014, April 25, 2013, and April 29, 2009.
Related executives
We found 11 more executives who work or worked at PhaseBio Pharmaceuticals and Ligand Pharmaceuticals.
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
Charles Berkman
Ligand Pharmaceuticals
General Counsel
Jonathan Mow
PhaseBio Pharmaceuticals
Chief Executive Officer
John Lee
PhaseBio Pharmaceuticals
Chief Medical Officer
John Sharp
PhaseBio Pharmaceuticals
Chief Financial Officer
Nishan de Silva
Ligand Pharmaceuticals